STI

New screening standards that illustrate the highest quality of sexual health care for MSM, expanding beyond federal guidelines to incorporate the collective experience of experts in the field of sexual health.

This information sheet highlights syphilis and HIV screening practices for pregnant women. The Centers for Disease Control and Prevention (CDC) recommends prenatal testing for syphilis and HIV during a woman’s first prenatal visit and repeat testing for “high-risk” mothers during the third trimester (preferably 28-32 weeks).

This slide set covers an array of incentives that can be provided by providers to increase chlamydia screening rates.

Infographic on how to create a teen-friendly reproductive and sexual health visit.

Infographic on STD screening of MSM, specifically of the throat and rectum.

Lauren Hunter, a doctoral student at UC Berkeley, presented the "Contraceptive method use and chlamydia positivity among California family planning clients: the case for new Multipurpose Prevention Technologies," an analysis comparing chlamydia positivity by type of contraceptive method used among women tested through California's Family PACT program in 2012-2013. In the presentation, she discusses the implications of the findings and how the development and provision of additional Multipurpose Prevention Technologies (MPTs) may help to address an unmet need for STI prevention.

Web page that provides general overview on Bacterial Vaginosis (BV). Includes facts, statistics, and what can be done to help prevent BV among women.

This fact sheet reports over 52,000 cases of chlamydia, gonorrhea, and syphilis, including a rise in congenital syphilis and significant racial disparities. It emphasizes routine testing, condom use, and partner communication to prevent and treat STIs statewide.

The 2024 US Preventive Services Task Force (USPSTF) Recommendation Statement reaffirms the importance of early screening for syphilis infection in all pregnant individuals to prevent congenital syphilis and associated complications. The report underscores timely testing—including repeat screening in high-risk cases—as a critical measure to safeguard maternal and infant health.

This webpage explains that persistent high-risk HPV—especially type 16—is a leading cause of oropharyngeal cancer, accounting for around 70% of U.S. throat cancers, and highlights prevention strategies like vaccination, sexual health practices, and regular screenings.